Home/Pipeline/LCAT Activity Assays

LCAT Activity Assays

Cardiovascular/Metabolic Disease (Pharmacodynamic Biomarker)

CommercialActive

Key Facts

Indication
Cardiovascular/Metabolic Disease (Pharmacodynamic Biomarker)
Phase
Commercial
Status
Active
Company

About Roar Biomedical

Roar Biomedical is a long-established, privately-held company operating as a specialized reagent and assay provider for the life sciences industry. Founded in 1997 and based in New York City, its core business revolves around proprietary fluorescence-based methods to measure protein activity, with a particular expertise in lipid transfer assays. The company generates revenue through product sales, licensing agreements, and co-branding partnerships, notably with MilliporeSigma, and its assays are utilized to support human clinical trials. It operates as a niche player with deep scientific validation but a limited public profile and product scope.

View full company profile